Ardea Biosciences, Inc.

Ardea Biosciences, Inc.

Ardea Biosciences, Inc., a biotechnology company, focuses on the discovery and development of small-molecule therapeutics for the treatment of gout, human immunodeficiency virus (HIV), cancer, and inflammatory diseases in the United States. The company's lead product candidate includes RDEA594, a product for the treatment of hyperuricemia and gout. Its other products comprise RDEA806 for the treatment of patients with HIV; and RDEA427, a second-generation NNRTI for the treatment of HIV, in a human micro-dose pharmacokinetic study. Ardea Biosciences is evaluating RDEA119, a non-ATP EK inhibitor, in a Phase I/II study in combination with sorafenib and as a single agent in a Phase I study, both in advanced cancer patients. It also develops RDEA436 for the treatment of inflammation. The company is based in San Diego, California.

Contact Details

Office Address

Ardea Biosciences, Inc.
4939 Directors Place
San Diego, CA, USA 92121
Phone: (858) 652-6500
Fax: (858) 625-0760


Chief Exec. Officer

Dr. Barry Quart Pharm.d.

Chief Financial Officer

Mr. John W. Beck

Business Reviews for Ardea Biosciences, Inc.

Related Companies